Sickle Cell Disease

Research in sickle cell disease investigates the genetic basis, cellular mechanisms, and clinical manifestations of this inherited blood disorder. Studies examine red blood cell sickling, vaso-occlusion, and end-organ damage, employing molecular biology, genetic sequencing, and advanced imaging techniques. Investigations also focus on developing and evaluating novel therapeutic strategies, including gene therapy and pharmacological interventions, as well as understanding patient experiences and health disparities.

Given the disproportionate impact of sickle cell disease on certain populations within Arkansas, this research holds significant public health relevance for the state. Understanding the disease's prevalence and specific challenges in Arkansas informs the development of targeted healthcare interventions and public health initiatives aimed at improving patient outcomes and reducing health inequities across the state.

This area of study intersects with fields such as meta-analysis, hematopoietic stem cell transplantation, and cardiovascular health. Engagement spans multiple institutions within Arkansas, fostering collaboration and comprehensive approaches to addressing sickle cell disease.